Inventor · disambiguated record
John Nieland
Also filed as: NIELAND JOHN · NIELAND JOHN D
8 granted patents·13 pending applications·125 citations·filing 1999–2019
84Inventor score
Files withMEDIGENE AG7ANAPHORE INC2UNIV LOYOLA CHICAGO2DEUTSCHES KREBSFOLSCHUNGSZENTR1LUDWIG MAXIMILLIANS UNI1
Top patents by PatentIndex Score
21 records- 0193US9624274B2Mutated structural protein of a parvovirusMEDIGENE AG·Filed 2012·Granted Apr 18, 2017·79 cites·16 claims
- 0279US6380364B1Chimeric biotin-binding papillomavirus proteinUNIV LOYOLA CHICAGO·Filed 1999·Granted Apr 30, 2002·38 cites·17 claims
- 0366US6838084B1Cytotoxic T-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapyMEDIGENE AG·Filed 2000·Granted Jan 4, 2005·5 cites·1 claims
- 0466US2020191788A1Mutated parvovirus structural proteins as vaccinesMEDIGENE AG·Filed 2019·Application pending·0 cites
- 0558US10822378B2Mutated structural protein of a parvovirusMEDIGENE AG·Filed 2017·Granted Nov 3, 2020·0 cites·16 claims
- 0657US7528168B2Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseasesNIELAND JOHN·Filed 2003·Granted May 5, 2009·2 cites·6 claims
- 0757US2010028995A1Tetranectin Trimerizing PolypeptidesANAPHORE INC·Filed 2009·Application pending·0 cites
- 0857US2010203083A1Mutated structural protein of a parvovirusMEDIGENE AG·Filed 2008·Application pending·0 cites
- 0956US2010297177A1Mutated parvovirus structural proteins as vaccinesLUDWIG MAXIMILLIANS UNI·Filed 2008·Application pending·0 cites
- 1053US2013288921A1Mutated parvovirus structural proteins as vaccinesMEDIGENE AG·Filed 2013·Application pending·0 cites
- 1151US2004258708A1Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapyFiled 2004·Application pending·0 cites
- 1250US10408834B2Mutated parvovirus structural proteins as vaccinesMEDIGENE AG·Filed 2015·Granted Sep 10, 2019·0 cites·24 claims
- 1348US2009143276A1Trimeric IL-1RaANAPHORE INC·Filed 2008·Application pending·0 cites
- 1447US2005025789A1Allogenic vaccine that contains a costimulatory polypeptide-expresing tumor cellFiled 2002·Application pending·0 cites
- 1547US2005085433A1Cellular vaccines comprising adjuvantsFiled 2002·Application pending·0 cites
- 1646US2001028883A1Papillomavirus cellular receptorFiled 2001·Application pending·0 cites
- 1745US2004101533A1Medicament for preventing or treating tumors caused by human papilloma virus type 18Filed 2001·Application pending·0 cites
- 1844US2004091479A1T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapyFiled 2001·Application pending·0 cites
- 1931US6242176B1Papillomavirus cellular receptorUNIV LOYOLA CHICAGO·Filed 1999·Granted Jun 5, 2001·1 cites·5 claims
- 2029US6911207B1Cytotoxic T-cell epitopes of the papillomavirus L1-protein and use thereof in diagnostics and therapyDEUTSCHES KREBSFOLSCHUNGSZENTR·Filed 2000·Granted Jun 28, 2005·0 cites·1 claims
- 2128US2005008614A1Topical use of cytokines and chemokines for the treatment of viral or mykotic skin diseases or tumoral diseasesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Nieland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →